Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China
· Delayed Price · Currency is CNY 5.88
-0.02 (-0.34%)
Apr 30, 2025, 3:04 PM CST
SHE:300039 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 6,150 | 6,464 | 6,956 | 8,431 | 6,443 | 5,094 | Upgrade
|
| Market Cap Growth | -7.07% | -7.07% | -17.49% | 30.84% | 26.49% | -2.79% | Upgrade
|
| Enterprise Value | 5,278 | 5,145 | 6,224 | 6,828 | 5,042 | 3,721 | Upgrade
|
| Last Close Price | 5.88 | 6.18 | 6.53 | 7.86 | 5.96 | 4.68 | Upgrade
|
| PE Ratio | 17.63 | 17.21 | 21.22 | 44.19 | 45.99 | 48.00 | Upgrade
|
| Forward PE | - | 24.15 | 24.15 | 24.15 | 24.15 | 24.15 | Upgrade
|
| PS Ratio | 4.17 | 4.39 | 4.36 | 7.54 | 5.86 | 5.61 | Upgrade
|
| PB Ratio | 1.50 | 1.58 | 1.73 | 2.24 | 2.12 | 1.98 | Upgrade
|
| P/TBV Ratio | 1.56 | 1.64 | 1.75 | 2.27 | 2.16 | 2.03 | Upgrade
|
| P/FCF Ratio | 44.43 | 46.70 | 19.67 | 24.45 | 77.14 | 21.52 | Upgrade
|
| P/OCF Ratio | 22.05 | 23.17 | 18.18 | 22.40 | 51.11 | 20.32 | Upgrade
|
| PEG Ratio | - | 0.97 | 0.97 | 0.97 | 0.97 | 0.97 | Upgrade
|
| EV/Sales Ratio | 3.38 | 3.49 | 3.91 | 6.10 | 4.58 | 4.10 | Upgrade
|
| EV/EBITDA Ratio | 14.52 | 12.70 | 18.06 | 32.02 | 32.91 | 30.80 | Upgrade
|
| EV/EBIT Ratio | 16.18 | 13.95 | 20.09 | 37.62 | 42.25 | 46.51 | Upgrade
|
| EV/FCF Ratio | 38.13 | 37.17 | 17.60 | 19.80 | 60.36 | 15.72 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | - | - | - | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | - | - | - | 0.30 | Upgrade
|
| Debt / FCF Ratio | 0.04 | 0.04 | - | - | - | 0.15 | Upgrade
|
| Asset Turnover | 0.32 | 0.32 | 0.36 | 0.29 | 0.35 | 0.32 | Upgrade
|
| Inventory Turnover | 1.52 | 1.52 | 1.88 | 1.52 | 1.31 | 0.95 | Upgrade
|
| Quick Ratio | 5.36 | 5.36 | 3.83 | 4.72 | 10.85 | 8.50 | Upgrade
|
| Current Ratio | 10.40 | 10.40 | 4.41 | 5.32 | 11.82 | 9.35 | Upgrade
|
| Return on Equity (ROE) | 9.22% | 9.22% | 8.39% | 5.59% | 4.98% | 4.12% | Upgrade
|
| Return on Assets (ROA) | 5.07% | 5.07% | 4.38% | 2.98% | 2.39% | 1.75% | Upgrade
|
| Return on Capital (ROIC) | 5.67% | 5.67% | 4.97% | 3.33% | 2.64% | 1.93% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.60% | 8.60% | 7.30% | 4.60% | 3.80% | 3.00% | Upgrade
|
| Earnings Yield | 6.11% | 5.81% | 4.71% | 2.26% | 2.17% | 2.08% | Upgrade
|
| FCF Yield | 2.25% | 2.14% | 5.08% | 4.09% | 1.30% | 4.65% | Upgrade
|
| Dividend Yield | 1.70% | - | 1.53% | 0.76% | 0.84% | 0.64% | Upgrade
|
| Payout Ratio | 27.86% | 27.86% | 19.14% | 27.41% | 22.59% | 98.56% | Upgrade
|
| Buyback Yield / Dilution | -0.00% | -0.00% | 0.02% | -0.01% | -0.04% | 1.31% | Upgrade
|
| Total Shareholder Return | 1.70% | -0.00% | 1.55% | 0.76% | 0.80% | 1.95% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.